Table 3.
Patient characteristics
| No. | Tumour type/Indication | Referral category | Age (yr) | Sex | BMI (kg/m2) | Glucose level (mg/dL) | Acc. time Gemini TF (min) | Acc. time Discovery MI (min) |
|---|---|---|---|---|---|---|---|---|
| 1 | Lung cancer | 1 | 70–80 | M | 26.3 | 109.8 | 81 | 123 |
| 2 | Malignancy? Vasculitis? | 1 | 60–70 | F | 24.7 | 106.2 | 74 | 113 |
| 3 | Pancreatic cancer | 2 | 70–80 | F | 24.2 | 108.0 | 63 | 102 |
| 4 | Lung cancer | 1 | 80–90 | F | 18.4 | 108.0 | 63 | 96 |
| 5 | Lung cancer | 1 | 70–80 | M | 28.4 | 109.8 | 65 | 100 |
| 6 | Malignant melanoma | 2 | 70–80 | M | 26.6 | 82.8 | 64 | 110 |
| 7 | Uterus cancer | 2 | 40–50 | F | 22.4 | 86.4 | 59 | 97 |
| 8 | Anal cancer | 2 | 40–50 | M | 25.1 | 86.4 | 60 | 93 |
| 9 | Pancreatic cancer | 2 | 70–80 | F | 21.6 | 122.4 | 104 | 61 |
| 10 | Lung cancer | 1 | 80–90 | M | 25.9 | 140.4 | 118 | 80 |
| 11 | Esophageal cancer | 1 | 40–50 | M | 23.0 | 113.4 | 120 | 76 |
| 12 | Sarcoidosis | 1 | 40–50 | M | 26.3 | 99.0 | 100 | 70 |
| 13 | Uterus cancer | 2 | 70–80 | F | 17.1 | 102.6 | 61 | 92 |
| 14 | Lung cancer | 1 | 60–70 | F | 31.6 | 100.8 | 81 | 62 |
| 15 | Lung cancer | 1 | 60–70 | F | 32.7 | 95.4 | 79 | 62 |
| 16 | Lung cancer | 1 | 60–70 | M | 23.9 | 104.4 | 82 | 61 |
*1, initial evaluation/diagnosis/staging; 2, follow-up after treatment. Acc. time accumulation time, BMI body mass index